← Back to Search

Brief treatment for insomnia for Sleep Disorders (H-FITS Trial)

N/A
Waitlist Available
Led By Charles Emery, Ph.D.
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from pre-intervention to 6 months post-intervention
Awards & highlights

H-FITS Trial Summary

Heart Failure Insomnia Treatment Study

Eligible Conditions
  • Sleep Disorders
  • Heart Failure
  • Congestive Heart Failure
  • Insomnia
  • Anxiety
  • Depression

H-FITS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from pre-intervention to 6 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from pre-intervention to 6 months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Anxiety
Attention and psychomotor performance
Decision making assessed by the GDT
+11 more

H-FITS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Brief treatment for insomniaExperimental Treatment1 Intervention
Brief Behavioral Treatment for Insomnia (BBTI) is a manualized, individual intervention designed to modify sleep patterns to reduce insomnia and improve sleep quality and efficiency. Participants complete two in-person meetings and two booster telephone calls over a four-week period.
Group II: Sleep MonitoringActive Control1 Intervention
Sleep Monitoring is an active comparator condition where participants track their sleep patterns for two weeks prior to the baseline and post-intervention assessments. They receive no contact from study staff during the intervening four-week period, except for a reminder call to begin completing the second sleep diary and to schedule the post-intervention assessment.

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
829 Previous Clinical Trials
505,543 Total Patients Enrolled
Charles Emery, Ph.D.Principal Investigator - Ohio State University
Ohio State University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~24 spots leftby Apr 2025